Estimating Lung Cancer and Cardiovascular Mortality in Female Breast Cancer Patients Receiving Radiotherapy
Overview
Authors
Affiliations
By integrating data of the PLCO cancer screening trial, SCORE-risk charts and radiotherapy excess ratios, we were able to create risk charts estimating radiotherapy-induced lung cancer and cardiovascular mortality in female breast cancer patients. These risk models might be useful to individualize radiotherapy and optimize lung cancer and cardiovascular prevention and screening.
Chen D, Xiao Y, Zhong K Zhongguo Fei Ai Za Zhi. 2022; 25(10):750-755.
PMID: 36167461 PMC: 9619345. DOI: 10.3779/j.issn.1009-3419.2022.101.46.
Schoepen M, Speleers B, De Neve W, Vakaet V, Deseyne P, Paelinck L J Appl Clin Med Phys. 2022; 23(11):e13720.
PMID: 36106550 PMC: 9680580. DOI: 10.1002/acm2.13720.
Quantifying Societal Burden of Radiation-Induced Cardiovascular Events in Breast Cancer Survivors.
Kimpe E, Werbrouck A, De Ridder M, Putman K Front Oncol. 2022; 12:869529.
PMID: 35494083 PMC: 9039176. DOI: 10.3389/fonc.2022.869529.
Prone versus supine free-breathing for right-sided whole breast radiotherapy.
Fargier-Bochaton O, Wang X, Dipasquale G, Laouiti M, Kountouri M, Gorobets O Sci Rep. 2022; 12(1):525.
PMID: 35017568 PMC: 8752750. DOI: 10.1038/s41598-021-04385-3.
Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.
Gupta S, Ahuja R, Sharma N, Singh P, Verma S, Gupta M Respir Med. 2021; 186:106531.
PMID: 34260977 PMC: 8261133. DOI: 10.1016/j.rmed.2021.106531.